NextPharma are a leading Pharmaceutical and Nutraceutical CDMO with 10 manufacturing sites in Europe. Each site is able to develop and produce dosage forms from the pre-clinical stage, through to commercialisation and routine supply.

Our expertise covers a wide variety of solid oral dosage forms, alongside liquids, suppositories, topical and ophthalmic products. Each site acts as a centre of excellence for at least one of these technologies.

Our NextPharma teams are vastly experienced in overcoming developmental challenges such as:

– Poor Aqueous Solubility
– Reduced Bioavailability
– Highly Potent APIs
– Sustained/Controlled Release Profiles
– Controlled Drug Substance

Type of Drugs Manufactured:

Small Molecule

CDMO Services:

Drug Product Formulation (FDF);Research & Development;Clinical Trials materials and logistics;Packaging;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

6-10

Please select any High Potent Products capabilities:

OEB 3;OEB 4-5;OEB >5

Facilities Locations:

Europe

Regulatory Approvals for your facilities:

FDA (United States);EMA (Europe);ISO;GMP;ANVISA (Brazil)

Manufacturing Technologies:

Blow-Fill-Seal (BFS);Liquids;Lyophilized amps/vials;Semi-solids;Soft Gels;Solids

Current Capacity:

Drug Product Formulation (FDF);Research & Development;Clinical Trials materials and logistics;Packaging;Regulatory Services;Analytical Development

NextPharma continues to enhance its offerings to meet the evolving needs of the pharmaceutical industry. For more information, please visit nextpharma.com.